Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129429509> ?p ?o ?g. }
- W2129429509 endingPage "103" @default.
- W2129429509 startingPage "96" @default.
- W2129429509 abstract "N-methyl-D-aspartate (NMDA) glutamate receptors mediate fast neurotransmission and regulate synaptic plasticity in the brain. Disruption of NMDA receptor-mediated signaling by noncompetitive antagonists, such as PCP or ketamine, evokes psychotomimetic behaviors, although the cellular mechanisms by which hypofunctional NMDA receptor signaling drives behavioral pathology are still unclear. Activation of glycogen synthase kinase-3 (GSK-3) has been implicated in the cellular neurotoxicity of NMDA receptor antagonists. Accordingly, in the present study we examined the ability of GSK-3 inhibitors, SB216763 and 1-azakenpaullone, to reverse the behavioral aberrations induced by ketamine. Male NMRI mice received intracerebroventricular (i.c.v.) injection of the GSK-3 inhibitors, SB216763 and 1-azakenpaullone, 5 min prior to ketamine administration. Locomotor activity, rotarod performance, prepulse inhibition, novel object recognition, and duration of loss of righting reflex were monitored. GSK-3 inhibitors attenuated ketamine-induced locomotor hyperactivity, motor incoordination, sensorimotor impairment, and cognitive deficits, but did not affect ketamine anesthesia. These data support an important role of GSK-3 in the expression of behavioral aberrations associated with NMDA receptor hypofunction, and suggest that GSK-3 inhibitors may ameliorate certain behavioral and cognitive dysfunctions in patients with schizophrenia." @default.
- W2129429509 created "2016-06-24" @default.
- W2129429509 creator A5015083798 @default.
- W2129429509 creator A5062847422 @default.
- W2129429509 creator A5066216265 @default.
- W2129429509 creator A5068341682 @default.
- W2129429509 date "2012-04-01" @default.
- W2129429509 modified "2023-10-06" @default.
- W2129429509 title "Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine" @default.
- W2129429509 cites W1507804974 @default.
- W2129429509 cites W1914381346 @default.
- W2129429509 cites W1918122080 @default.
- W2129429509 cites W1964021320 @default.
- W2129429509 cites W1965632303 @default.
- W2129429509 cites W1966715692 @default.
- W2129429509 cites W1968620438 @default.
- W2129429509 cites W1970070877 @default.
- W2129429509 cites W1976646070 @default.
- W2129429509 cites W1979993283 @default.
- W2129429509 cites W1982958012 @default.
- W2129429509 cites W1983539644 @default.
- W2129429509 cites W1985807703 @default.
- W2129429509 cites W1991871366 @default.
- W2129429509 cites W1994875311 @default.
- W2129429509 cites W1995540460 @default.
- W2129429509 cites W2000216435 @default.
- W2129429509 cites W2003712515 @default.
- W2129429509 cites W2014409883 @default.
- W2129429509 cites W2016350888 @default.
- W2129429509 cites W2018713267 @default.
- W2129429509 cites W2024217117 @default.
- W2129429509 cites W2028494426 @default.
- W2129429509 cites W2028884770 @default.
- W2129429509 cites W2029925498 @default.
- W2129429509 cites W2038587452 @default.
- W2129429509 cites W2040479649 @default.
- W2129429509 cites W2045696000 @default.
- W2129429509 cites W2048479922 @default.
- W2129429509 cites W2051788298 @default.
- W2129429509 cites W2054148524 @default.
- W2129429509 cites W2058426499 @default.
- W2129429509 cites W2058459224 @default.
- W2129429509 cites W2061711185 @default.
- W2129429509 cites W2070309123 @default.
- W2129429509 cites W2075225068 @default.
- W2129429509 cites W2084253035 @default.
- W2129429509 cites W2084460664 @default.
- W2129429509 cites W2086048722 @default.
- W2129429509 cites W2087201853 @default.
- W2129429509 cites W2099078941 @default.
- W2129429509 cites W2099989397 @default.
- W2129429509 cites W2102501805 @default.
- W2129429509 cites W2105911676 @default.
- W2129429509 cites W2117374256 @default.
- W2129429509 cites W2124578903 @default.
- W2129429509 cites W2125904354 @default.
- W2129429509 cites W2125996653 @default.
- W2129429509 cites W2134773980 @default.
- W2129429509 cites W2144035284 @default.
- W2129429509 cites W2158321076 @default.
- W2129429509 cites W2165378197 @default.
- W2129429509 cites W2178382797 @default.
- W2129429509 cites W4247527278 @default.
- W2129429509 cites W4849013 @default.
- W2129429509 doi "https://doi.org/10.1016/j.schres.2012.01.024" @default.
- W2129429509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22325078" @default.
- W2129429509 hasPublicationYear "2012" @default.
- W2129429509 type Work @default.
- W2129429509 sameAs 2129429509 @default.
- W2129429509 citedByCount "41" @default.
- W2129429509 countsByYear W21294295092012 @default.
- W2129429509 countsByYear W21294295092013 @default.
- W2129429509 countsByYear W21294295092014 @default.
- W2129429509 countsByYear W21294295092015 @default.
- W2129429509 countsByYear W21294295092016 @default.
- W2129429509 countsByYear W21294295092017 @default.
- W2129429509 countsByYear W21294295092018 @default.
- W2129429509 countsByYear W21294295092019 @default.
- W2129429509 countsByYear W21294295092020 @default.
- W2129429509 countsByYear W21294295092021 @default.
- W2129429509 crossrefType "journal-article" @default.
- W2129429509 hasAuthorship W2129429509A5015083798 @default.
- W2129429509 hasAuthorship W2129429509A5062847422 @default.
- W2129429509 hasAuthorship W2129429509A5066216265 @default.
- W2129429509 hasAuthorship W2129429509A5068341682 @default.
- W2129429509 hasConcept C118552586 @default.
- W2129429509 hasConcept C126322002 @default.
- W2129429509 hasConcept C134018914 @default.
- W2129429509 hasConcept C141421786 @default.
- W2129429509 hasConcept C15744967 @default.
- W2129429509 hasConcept C169760540 @default.
- W2129429509 hasConcept C170493617 @default.
- W2129429509 hasConcept C182996813 @default.
- W2129429509 hasConcept C192118531 @default.
- W2129429509 hasConcept C2776412080 @default.
- W2129429509 hasConcept C2777499176 @default.
- W2129429509 hasConcept C2779491297 @default.
- W2129429509 hasConcept C2780795376 @default.